<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01798719</url>
  </required_header>
  <id_info>
    <org_study_id>EPINUT3</org_study_id>
    <nct_id>NCT01798719</nct_id>
  </id_info>
  <brief_title>Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease</brief_title>
  <acronym>Nutriepa</acronym>
  <official_title>Low Glycemic Index Mediterranean Diet Effect on Moderate or Severe Non-alcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-alcoholic fatty liver disease (NAFLD) is a clinical/biochemical condition associated with
      the metabolic syndrome. As the disease stems from excess calorie intake and lack of physical
      activity, the correction of unhealthy lifestyles is the background of any prevention and
      treatment strategy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The majority of NAFLD patients are characterized by high body mass index, insulin resistance
      and they show a remarkably higher energy intake in comparison to individuals without hepatic
      steatosis. Several authors have proposed dietary weight loss strategies to ameliorate or
      reverse fatty liver because of the potential role of weight loss on the supposed risk factors
      of liver injury, mainly insulin resistance, free fatty acid levels, and pro-inflammatory and
      profibrotic adipokines. There are no definite data regarding how much and how rapidly weight
      loss should be to have the more favorable effects, but in obese children, the larger the
      weight loss, the larger the decrease of liver enzyme levels and the lower the prevalence of
      NAFLD. The American Gastroenterological Association recommends a weight loss target of 10% of
      baseline. A loss of at least 10% of body weight in obese patients is associated with a
      normalization of previously abnormal liver function tests as well as decreased hepatomegaly,
      but even a moderate weight loss (approximately 6% of baseline weight) can improve insulin
      resistance and intrahepatic liver content.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non-alcoholic Fatty Liver Disease Ultrasonography Score</measure>
    <time_frame>Six months</time_frame>
    <description>A semiquantitative score to measure Non-alcoholic Fatty Liver Disease will be used</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>NAFLD</condition>
  <arm_group>
    <arm_group_label>Diet: Dietary Advice</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Some general dietary advice about healthy dietary components, servings size and frequency of servings</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low glycemic index Mediterranean Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low glycemic index Mediterranean Diet prescription with indication about type of foods than can be consumed frequently (green foods), sometimes (yellow foods) and never (red foods)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Glycemic Index Mediterranean Diet</intervention_name>
    <description>A list of foods that may be consumed frequently (green foods), sometimes (yellow foods) and never (red foods)</description>
    <arm_group_label>Low glycemic index Mediterranean Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>General Advice</intervention_name>
    <description>Only general advice about diet</description>
    <arm_group_label>Diet: Dietary Advice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject enrolled in the cohort Nutriep assembled in 2005-2007

          -  Moderate or severe NAFLD

        Exclusion Criteria:

          -  Middle NAFLD

          -  Not enrolled in the Nutriep cohort

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alberto R Osella, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Saverio de Bellis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Misciagna, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS Saverio de Bellis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratory of Epidemiology and Biostatistics, IRCCS Saverio de Bellis</name>
      <address>
        <city>Castellana Grotte</city>
        <state>BA</state>
        <zip>70013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Cozzolongo R, Osella AR, Elba S, Petruzzi J, Buongiorno G, Giannuzzi V, Leone G, Bonfiglio C, Lanzilotta E, Manghisi OG, Leandro G; NUTRIHEP Collaborating Group, Donnaloia R, Fanelli V, Mirizzi F, Parziale L, Crupi G, Detomaso P, Labbate A, Zizzari S, Depalma M, Polignano A, Lopinto D, Daprile G. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol. 2009 Nov;104(11):2740-6. doi: 10.1038/ajg.2009.428. Epub 2009 Jul 28.</citation>
    <PMID>19638964</PMID>
  </reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2013</study_first_submitted>
  <study_first_submitted_qc>February 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2013</study_first_posted>
  <last_update_submitted>February 26, 2013</last_update_submitted>
  <last_update_submitted_qc>February 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</investigator_affiliation>
    <investigator_full_name>Alberto R Osella</investigator_full_name>
    <investigator_title>Senior Researcher</investigator_title>
  </responsible_party>
  <keyword>NAFLD</keyword>
  <keyword>Clinical Trial</keyword>
  <keyword>Mediterranean Diet</keyword>
  <keyword>Low Glycemic Index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

